Denti, Michela Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 10.472
AS - Asia 3.347
EU - Europa 2.893
SA - Sud America 520
Continente sconosciuto - Info sul continente non disponibili 261
AF - Africa 67
OC - Oceania 11
Totale 17.571
Nazione #
US - Stati Uniti d'America 10.221
SG - Singapore 1.424
CN - Cina 674
VN - Vietnam 619
IT - Italia 471
RU - Federazione Russa 445
BR - Brasile 417
SE - Svezia 363
UA - Ucraina 326
FI - Finlandia 306
GB - Regno Unito 232
DE - Germania 187
FR - Francia 160
CA - Canada 150
LV - Lettonia 128
KR - Corea 127
IN - India 86
BD - Bangladesh 70
NL - Olanda 66
BG - Bulgaria 50
HK - Hong Kong 41
ES - Italia 40
ID - Indonesia 35
TR - Turchia 33
IQ - Iraq 32
JO - Giordania 30
AR - Argentina 28
ZA - Sudafrica 26
MX - Messico 25
PL - Polonia 25
JP - Giappone 23
VE - Venezuela 21
IR - Iran 19
AT - Austria 17
CO - Colombia 17
MY - Malesia 17
PK - Pakistan 17
CR - Costa Rica 16
LT - Lituania 16
JM - Giamaica 15
EC - Ecuador 13
IL - Israele 12
IE - Irlanda 11
PH - Filippine 11
AU - Australia 9
TH - Thailandia 9
UZ - Uzbekistan 9
CL - Cile 8
NP - Nepal 8
BE - Belgio 7
CH - Svizzera 7
EG - Egitto 7
GT - Guatemala 7
KE - Kenya 7
SA - Arabia Saudita 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
PR - Porto Rico 6
KZ - Kazakistan 5
RO - Romania 5
SV - El Salvador 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
EE - Estonia 4
ET - Etiopia 4
GR - Grecia 4
HN - Honduras 4
HR - Croazia 4
NI - Nicaragua 4
OM - Oman 4
PY - Paraguay 4
SC - Seychelles 4
TN - Tunisia 4
AL - Albania 3
BS - Bahamas 3
DO - Repubblica Dominicana 3
LK - Sri Lanka 3
MM - Myanmar 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
TW - Taiwan 3
BB - Barbados 2
BM - Bermuda 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
Totale 17.296
Città #
Ashburn 1.031
Singapore 885
Chandler 832
Jacksonville 679
Fairfield 649
San Jose 634
Dallas 363
Columbus 331
Woodbridge 322
Council Bluffs 301
Santa Clara 293
Wilmington 279
Houston 270
Seattle 270
Ann Arbor 240
San Mateo 235
Cambridge 213
Princeton 207
Moscow 195
Beijing 185
Helsinki 176
Ho Chi Minh City 168
New York 149
The Dalles 140
Hanoi 139
Los Angeles 131
Riga 128
Seoul 123
Phoenix 119
Lauterbourg 110
Trento 92
Dearborn 80
Boardman 75
Buffalo 68
Hefei 61
North Bergen 55
São Paulo 54
San Diego 51
Munich 49
Milan 48
Sofia 46
Orem 44
London 40
Chicago 39
Bremen 36
Denver 34
Fremont 34
Hong Kong 33
Rome 33
Da Nang 31
Dong Ket 31
Toronto 31
Lawrence 29
Delft 28
Ottawa 28
Jakarta 26
Brooklyn 25
Haiphong 24
Chennai 23
Frankfurt am Main 23
Warsaw 22
Como 21
Lappeenranta 20
Johannesburg 19
Norwalk 19
Stockholm 19
Tokyo 19
Atlanta 18
Montreal 18
Poplar 17
Redondo Beach 17
San Paolo di Civitate 17
Calgary 15
Guangzhou 15
Manchester 15
Nuremberg 15
Tehran 15
Verona 15
Belo Horizonte 14
Biên Hòa 14
Charlotte 14
Des Moines 14
Izmir 14
Washington 14
Amsterdam 12
Mumbai 12
Boston 11
Kilburn 11
New Delhi 11
San Francisco 11
San José 11
Shanghai 11
Badajoz 10
Hillsboro 10
Hải Dương 10
Ipoh 10
Kingston 10
Rio de Janeiro 10
Salt Lake City 10
Vienna 10
Totale 11.638
Nome #
The short-term impact of probiotic consumption on the oral cavity microbiome 305
The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis 252
Enhanced microbial diversity in the saliva microbiome induced by short-term probiotic intake revealed by 16S rRNA sequencing on the IonTorrent PGM platform 238
A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice 234
A new splicing isoform of Cacna2d4 mimicking the effects of c.2451insC mutation in the retina: Novel molecular and electrophysiological insights 230
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 225
Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations 216
RNA intereference mediated therapy for neurodegenerative diseases 215
Reduced miR-659-3p levels correlate with progranulin increase in hypoxic conditions: Implications for frontotemporal dementia 215
Statistical analysis of a Bayesian classifier based on the expression of miRNAs 213
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells 210
An electroporation protocol for efficient DNA transfection in PC12 cells 209
Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation 207
Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects 194
Oligonucleotide therapy 193
microRNAs make the call in cancer personalized medicine 192
Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases 190
Splicing-correcting therapeutic approaches for retinal dystrophies: where endogenous gene regulation and specificity matter. 188
microRNA-375 expression distinguishes neuroendocrine from non-neuroendocrine lung tumours in FFPE samples 187
Comparison of different methods to extract RNA from cardiac tissue for miRNA profiling by qRT-PCR 184
A network in FrontoTemporal Dementia - an RNA perspective 182
Delivery is key: Lessons learnt from developing splice-switching antisense therapies 182
A novel RNA-binding protein from Triturus carnifex identified by RNA-ligand screening with the newt hammerhead ribozyme 181
AAV-Mediated Allele-Specific RNA Interference of a Common Dominant Rhodopsin Mutation Causing Retinitis Pigmentosa 180
New Platform for the Direct Profiling of microRNAs in Biofluids 178
Antisense RNA-mediated exon skipping in gene therapy 177
DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer 176
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 174
AAV-mediated Allele-specific RNA interference of a common dominant Rhodopsin mutation causing Retinitis Pigmentosa 173
miR-205 expression levels in non-small cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. 172
A chimeric adeno-associated virus/antisense-U1small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice 170
Circulating miR-127-3p as a potential biomarker for differential diagnosis in frontotemporal dementia 170
MiRNA-QC-and-Diagnosis: An R package for diagnosis based on MiRNA expression 170
A loxP-containing pol II promoter for RNA interference is reversibly regulated by Cre recombinase 169
MicroRNAs in epithelial ovarian cancer 167
Identification of new p53 target microRNAs by bioinformatics and functional analysis 167
Delivery of oligonucleotide-based therapeutics: challenges and opportunities 166
A new vector, based on the polII promoter of U1 snRNA gene, for the expression of siRNAs in mammalian cells 164
Upregulation of miR-133b and miR-328 in Patients With Atrial Dilatation: Implications for Stretch-Induced Atrial Fibrillation 164
miR375-3p Distinguishes Low-Grade Neuroendocrine From Non-neuroendocrine Lung Tumors in FFPE Samples 164
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 162
Functional analysis of miRNAs involved in the regulation of the transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8 in epithelial ovarian cancer 162
MicroRNAs as lung cancer biomarkers 161
Heterogeneity of Large Cell Carcinoma of the Lung: An Immunophenotypic and miRNA-Based Analysis. 160
71 nucleotides from the terminal right part of PSTVd is the sufficient minimum of RNA capable of sustaining specific binding to tomato protein Virp1 156
Antisense RNA-induced exon-skipping for the gene therapy of frontotemporal dementia and parkinsonism associated with chromosome 17 (ftdp-17) 156
MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration 153
Long term benefit of AAV/antisense-mediated exon skipping in dystrophic mice 150
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice 150
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 150
Circulating microRNAs in Neurodegenerative Diseases 150
MicroRNA and Lung Cancer 147
A vector for siRNA expression in mammalian cells that relies on polII-dependent transcription and produces asymmetric accumulation of one siRNA strand 146
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 145
Measurements methods for the development of microRNA-based tests for cancer diagnosis 144
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 143
Analisi della struttura e dell¿attivit¿ autocatalitica di trascritti dimerici ¿BglII¿ in Triturus 143
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders 141
Small RNA molecules of great utility as diagnostic biomarkers in lung cancer 136
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model 135
Exon Skipping Through Chimeric Antisense U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect 132
Antisense RNA-mediated exon-skipping for gene therapy 130
Fabry Disease: Antisense Therapeutics for intronic variations causing mis-spliced messenger RNA and active-site-specific chaperones (ASSC) for conformational enzyme defects 130
Integrative microRNAome analysis of skeletal muscle of Colossoma macropomum (tambaqui), Piaractus mesopotamicus (pacu), and the hybrid tambacu, based on next-generation sequencing data 130
mRNA fate: Life and death of the mRNA in the cytoplasm 128
Circulating cell-free microRNAs as biomarkers for neurodegenerative diseases 128
HCS-Splice: A High-Content Screening Method to Advance the Discovery of RNA Splicing-Modulating Therapeutics 127
New circuits between miRNAs and transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8: possible identification of therapeutic targets for epithelial ovarian cancer treatment 127
PMP70 knock-down generates oxidative stress and pro-inflammatory cytokine production in C6 glial cells 125
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study 124
Short interfering RNAs specific for potato spindle tuber viroid are found in the cytoplasm but not in the nucleus 124
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 122
Il ribozima di tritone: struttura ed applicazioni 122
Replicating potato spindle tuber viroid RNA is accompanied by short RNA fragments that are characteristic of post-transcriptional gene silencing 118
RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: a model system to study PMP70 function 117
miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia 116
Uso di un ribozima di vertebrati per l'inattivazione del gene MGMT in cellule CHO 116
The newt hammerhead ribozyme: structure and applications 114
AAV-mediated retinal gene transfer in animal models of retinal degeneration 113
Virp1 is a host protein with a major role in potato spindle tuber viroid infection in Nicotiana plants 111
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia 110
SA-ODG platform: a semi-automated and PCR-free method to analyse microRNAs in solid tissues 110
MicroRNAs in epithelial ovarian cancer 108
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 107
News from around the RNA world: new avenues in RNA biology, biotechnology and therapeutics from the 2022 SIBBM meeting 106
La ribonucleoparticella del ribozima di tritone: fossile molecolare o una nuova particella coinvolta nel ¿processing¿ dell¿RNA? 106
Uso di nuove proprietà dell' RNA per la terapia genica di infezioni da HIV = Use of new RNA properties for gene therapy of HIV infections 106
Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model 105
Study on the affinity and specificity of the interaction between Potato Spindle Tuber viroid and tomato protein Virp1 104
Towards functional analysis of BVRB, a gene encoding for a viroid binding protein 103
Identification of miRNAs Bound to an RNA of Interest by MicroRNA Capture Affinity Technology (miR-CATCH) 101
Exon-skipping mediated by the systemic delivery of AAV constructs expressing antisense-snRNAs restores dystrophin and muscular functionality in body-wide skeletal muscles of mdx mice 98
Body-wide rescue of dystrophin and muscle function in mdx mice by antisense-snRNAs mediated exon-skipping 97
U1snRNA-mediated exon skipping for the therapy of Duchenne Muscular Dystrophy: towards a clinical trial 97
Replicating viroid RNA is accompanied by short RNA fragments that are characteristic of posttranscriptional gene silencing 97
Mutual feedback regulation between Poly(A)-specific ribonuclease (PARN) and cognate microRNAs 96
The motif in the Terminal Right Part of Potato Spindle Tuber Viroid is the determinant of specific in vitro recognition by tomato RNA-binding protein Virp1 96
Possible use of a naturally-occurring vertebrate hammerhead ribozyme to suppress human O-6-MGMT expression in CHO cells 96
Characterisation of the protein components of the newt hammerhead ribozyme RNP 95
Use of new RNA properties for gene therapy of HIV infections 94
Totale 15.219
Categoria #
all - tutte 70.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.382
selected - selezionate 0
volume - volumi 3.973
Totale 75.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022912 0 0 0 0 89 25 46 202 75 125 103 247
2022/20231.714 239 198 26 266 191 257 7 117 238 12 76 87
2023/2024658 48 53 38 24 67 153 44 56 6 59 32 78
2024/20252.603 15 29 128 508 121 341 44 178 286 491 203 259
2025/20265.248 437 110 647 779 555 459 919 146 422 429 228 117
2026/20271.978 124 278 678 841 57 0 0 0 0 0 0 0
Totale 17.571